Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||
| Earning before tax | 256.37%213.48M | 113.08%79.04M | ---136.52M | 57.13%-73.37M | 65.09%-604.38M | ---171.16M | -320.47%-1.73B | ---411.7M |
| Profit adjustment | ||||||||
| Interest (income) - adjustment | 23.99%-14.96M | -12.63%-37.43M | ---19.68M | -67.91%-10.46M | -85.68%-33.23M | ---6.23M | -119.45%-17.9M | ---8.16M |
| Investment loss (gain) | ---- | 96.89%-205K | ---- | ---- | 30.58%-6.6M | ---5.08M | -435.27%-9.5M | ---1.78M |
| Attributable subsidiary (profit) loss | -19.80%-160.25M | -1,305.45%-302.5M | ---133.76M | -4,366.13%-77.22M | 2,818.74%25.09M | --1.81M | ---923K | ---- |
| Impairment and provisions: | 34.42%27.06M | -78.32%65.1M | --20.13M | -81.23%4.75M | -78.91%300.26M | --25.28M | 1,359.21%1.42B | --97.58M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | -97.15%6.98M | ---- | --244.64M | ---- |
| -Impairmen of inventory (reversal) | 3.92%21.88M | -80.39%55.4M | --21.05M | -60.14%10.22M | -51.24%282.44M | --25.64M | 671.04%579.26M | --75.13M |
| -Other impairments and provisions | 662.65%5.18M | -10.45%9.71M | ---921K | -1,429.33%-5.48M | -98.19%10.84M | ---358K | 2,572.03%600.06M | --22.46M |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---6.4M | ---- |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---6.4M | ---- |
| Asset sale loss (gain): | --11.11M | 764.93%8.8M | ---- | 2,530.77%342K | 83.93%-1.32M | --13K | -8,051.49%-8.23M | ---101K |
| -Loss (gain) on sale of property, machinery and equipment | --11.11M | 764.93%8.8M | ---- | 2,530.77%342K | 83.93%-1.32M | --13K | -8,051.49%-8.23M | ---101K |
| Depreciation and amortization: | 27.57%358.08M | 47.14%608.94M | --280.69M | 29.50%134.51M | 40.77%413.85M | --103.87M | 58.34%294M | --185.67M |
| -Amortization of intangible assets | 5.39%42.33M | -0.95%78.74M | --40.16M | 3.87%20.08M | 4.03%79.5M | --19.33M | 5.20%76.42M | --72.64M |
| Financial expense | 6.95%68.22M | 80.51%132.59M | --63.79M | 134.09%31.46M | 123.31%73.45M | --13.44M | -53.16%32.89M | --70.22M |
| Special items | -5.99%21.32M | 34.11%58.88M | --22.67M | 36.88%13.81M | 8.32%43.9M | --10.09M | 79.24%40.53M | --22.61M |
| Operating profit before the change of operating capital | 438.54%524.05M | 190.59%613.22M | --97.31M | 185.15%23.82M | 1,113.97%211.03M | ---27.97M | 138.09%17.38M | ---45.64M |
| Change of operating capital | ||||||||
| Inventory (increase) decrease | -41.82%-256.09M | -203.11%-120.35M | ---180.57M | -409.14%-92.71M | 112.40%116.73M | --29.99M | -110.86%-941.52M | ---446.52M |
| Accounts receivable (increase)decrease | -33.05%-131.89M | 42.15%-483.79M | ---99.13M | 384.19%220.82M | 39.08%-836.22M | ---77.7M | -869.36%-1.37B | ---141.6M |
| Accounts payable increase (decrease) | 60.66%-157.54M | 6.32%188.16M | ---400.49M | 60.68%-276.87M | -95.94%176.97M | ---704.17M | 299.34%4.36B | --1.09B |
| prepayments (increase)decrease | -368.92%-79.91M | -81.98%20.63M | --29.72M | 87.55%-6.81M | 134.96%114.51M | ---54.68M | -538.42%-327.53M | --74.71M |
| Special items for working capital changes | -117.10%-39M | -225.37%-616.37M | --228.03M | 104.78%445.31M | 224.24%491.63M | --217.47M | 43.99%-395.72M | ---706.47M |
| Cash from business operations | 56.82%-140.37M | -245.10%-398.5M | ---325.12M | 150.82%313.56M | -79.51%274.64M | ---617.06M | 872.36%1.34B | ---173.58M |
| Other taxs | ---341K | 99.70%-70K | ---- | ---- | -381.39%-23.51M | ---379K | ---4.88M | ---- |
| Interest received - operating | -23.99%14.96M | 12.63%37.43M | --19.68M | 67.91%10.46M | 85.68%33.23M | --6.23M | 119.45%17.9M | --8.16M |
| Net cash from operations | 58.83%-125.75M | -227.00%-361.14M | ---305.44M | 153.01%324.02M | -78.99%284.35M | ---611.21M | 918.31%1.35B | ---165.42M |
| Cash flow from investment activities | ||||||||
| Dividend received - investment | 58.76%295.64M | --186.22M | --186.22M | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | -59.45%178K | -52.43%3.53M | --439K | -83.11%294K | -40.70%7.42M | --1.74M | 3,736.50%12.51M | --326K |
| Purchase of fixed assets | -472.32%-1.6B | 22.35%-614.8M | ---279.28M | 44.57%-155.22M | 70.54%-791.75M | ---280.02M | -199.96%-2.69B | ---896.12M |
| Purchase of intangible assets | ---- | 53.04%-10.33M | ---- | 2.51%-389K | -12.41%-21.99M | ---399K | -3,238.74%-19.57M | ---586K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---239.54M | ---- |
| Recovery of cash from investments | ---- | -99.98%205K | ---- | ---- | 201.96%1.17B | --820.65M | -287.33%-1.15B | --612.11M |
| Cash on investment | ---- | -130.67%-346M | ---346M | ---346M | ---150M | ---- | ---- | ---- |
| Other items in the investment business | ---- | -93.31%6.01M | ---- | ---- | 31.54%89.9M | ---- | --68.34M | ---- |
| Net cash from investment operations | -196.97%-1.3B | -356.05%-775.16M | ---438.61M | -192.50%-501.32M | 107.54%302.73M | --541.97M | -1,311.63%-4.01B | ---284.28M |
| Net cash before financing | -91.96%-1.43B | -293.55%-1.14B | ---744.05M | -156.07%-177.3M | 122.08%587.09M | ---69.24M | -491.35%-2.66B | ---449.7M |
| Cash flow from financing activities | ||||||||
| New borrowing | 76.55%1.6B | 12.09%1.37B | --904.14M | 196.06%951.96M | -57.69%1.22B | --321.55M | 4,083.23%2.89B | --69M |
| Refund | -4.71%-629.33M | -56.38%-901M | ---601M | ---489.1M | -90.14%-576.17M | ---- | 17.66%-303.02M | ---368M |
| Issuing shares | --903.26M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | -27.63%-78.94M | 5.78%-125.7M | ---61.85M | -4.02%-33.76M | -21.46%-133.41M | ---32.45M | -843.20%-109.84M | ---11.65M |
| Absorb investment income | ---- | 19,340.12%1B | ---- | ---- | -99.79%5.14M | ---- | 87.22%2.41B | --1.29B |
| Issuance expenses and redemption of securities expenses | 40.31%-1.08M | ---6.37M | ---1.82M | ---- | ---- | ---- | ---- | ---- |
| Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---100M | 200.00%38.7M | ---- | ---38.7M | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---1.97B | ---- |
| Net cash from financing operations | 662.14%1.78B | 154.02%1.3B | --234.04M | 14.99%325.58M | -81.90%511.03M | --283.13M | 200.93%2.82B | --938.32M |
| Effect of rate | -4,909.09%-5.82M | --2.98M | --121K | --246K | ---- | ---- | 129.74%4.38M | ---14.72M |
| Net Cash | 169.69%355.44M | -85.26%161.81M | ---510.01M | -30.67%148.28M | 568.05%1.1B | --213.89M | -66.36%164.38M | --488.62M |
| Begining period cash | 8.10%2.2B | 117.30%2.03B | --2.03B | 117.30%2.03B | 21.99%936.16M | --936.16M | 161.46%767.41M | --293.51M |
| Cash at the end | 67.19%2.55B | 8.10%2.2B | --1.52B | 89.80%2.18B | 117.30%2.03B | --1.15B | 21.99%936.16M | --767.41M |
| Cash balance analysis | ||||||||
| Cash and bank balance | ---- | 30.01%3.26B | ---- | 42.68%2.68B | 27.14%2.51B | --1.88B | 10.28%1.97B | --1.79B |
| Cash and cash equivalent balance | ---- | 30.01%3.26B | ---- | 42.68%2.68B | 27.14%2.51B | --1.88B | 10.28%1.97B | --1.79B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young Accounting Firm | -- | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.